Pallas vs Sprout: GLP-1 Telehealth Compared

Sprout (Sprout Health) is one of the newer entrants in compounded GLP-1 telehealth, advertising low entry prices, fast prescribing, and a flat-price-at-every-dose pledge. Pallas Health shares several of those traits — no membership, flat dosing, free shipping — so this comparison is mostly about what's published versus what isn't, and the terms that apply when plans change.

This is an honest comparison. Pricing on both sides changes often; figures reflect each platform's published pricing as of August 2026 — confirm current numbers on both sites before signing up.

The three differences that matter most

1. Published renewal terms. Sprout advertises compounded semaglutide "starting at $149/month" and tirzepatide at $199/month — but its ongoing renewal prices aren't published on the site; they appear at checkout. Pallas prints the whole arc in one sentence on every surface: $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. Whichever platform you choose, get the renewal number in writing before you pay.
2. The refund mechanics. Per Sprout's published policy, refunds are full before a provider reviews your intake; after review but before pharmacy fulfillment, a flat $50 clinical review fee is withheld; after fulfillment, orders are non-refundable — and cancellation needs 48 hours' notice before billing. Pallas refunds in full if a clinician decides treatment isn't right for you, with cancel-anytime terms and no fees withheld.
3. State coverage. Per its own terms, Sprout doesn't serve Alabama, Arkansas, Mississippi, Louisiana, California, or North Dakota. Pallas serves all 50 states plus DC.

Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.

Quick comparison

What Sprout does well

Low advertised entry pricing. Sprout's $149 semaglutide and $199 tirzepatide entry prices — with promo codes running on top — are among the lower advertised numbers in the category, with free shipping and no membership fee, and it pledges that your price won't rise as your dose does.

Fast prescribing. Sprout advertises clinician review and, when appropriate, a prescription within 24–48 hours of its quiz-based intake, through a physician-only clinical network.

What Pallas does differently

Everything on the label. Pallas publishes the full pricing arc — intro, renewal amount, interval, and monthly average — in one sentence on every surface: $139 for your first month, then $597 every 12 weeks ($199/mo average). Cancel anytime. Tirzepatide is $179 for your first month, then $897 every 12 weeks ($299/mo average). Cancel anytime. No checkout reveal, no fee schedule to discover later.

Stronger exit terms. Full refund if a clinician doesn't prescribe — no $50 withholding. Cancel anytime, no notice window, self-serve in the portal.

Every state, both tiers, verifiable. All 50 states plus DC, brand-name medications dispensed cash-pay from $1,069/month (roughly $700–900/month below Sprout's listed brand prices), and LegitScript Healthcare Merchant Certification you can confirm in LegitScript's public database. The free Pallas companion app (iOS and Android) covers protein, steps, weight trend, and dose reminders.

Who should pick which

Sprout may fit if:

• Its advertised entry price plus a current promo code beats what you've found elsewhere — after you've confirmed the renewal price at checkout
• You live in one of its 44 covered states and want a quiz-fast intake

Pallas is probably the better fit if:

• You want the renewal price published before you start, not revealed at checkout
• You want a full refund if a clinician doesn't prescribe, with no review fee withheld
• You live in Alabama, Arkansas, Mississippi, Louisiana, California, or North Dakota — or want DC coverage
• You may want brand-name medication — Pallas's brand tier is substantially cheaper
• You want a verifiable LegitScript-certified platform with a self-serve portal

Switching between them

Bring your medication name, current dose, and titration history, and mind Sprout's 48-hour billing notice when timing a switch. A Pallas clinician picks up from your current dose — no restart of titration unless you've been off medication for more than four weeks. For the clinical side of choosing between molecules, see semaglutide vs tirzepatide.

References

Platform pricing and program details reflect each company's publicly published terms as of August 2026 and change frequently — confirm current numbers on each platform's site before enrolling. The regulatory basis for compounded preparations is summarized by the FDA.

1. Sprout Health. Pricing and refund policy, as published August 2026.
2. U.S. Food and Drug Administration. Warning letter to Sprout Health Partners LLC (MARCS-CMS 715879). September 9, 2025.
3. U.S. Food and Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. 2025.

Bottom line: Sprout advertises sharp entry prices with a flat-dose pledge and fast prescribing — with renewal prices revealed at checkout, a $50 fee withheld on post-review refunds, and six states unserved. Pallas publishes the entire price arc up front, refunds in full if a clinician doesn't prescribe, serves every state, and dispenses brand-name medication at far lower cash prices. If an entry-price promo decides it for you, confirm Sprout's renewal number first; if published terms and exit flexibility decide it, that's what Pallas is built on.